The latest pregnant women living with hiv antiretroviral therapy coverage for pmtct data in Iran reports 37%, an decrease of 4% (-9.8%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Iran
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Iran
PMTCT antiretroviral therapy coverage
More indicators for Iran
Iran PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 37% | -4% |
| 2021 | 41% | -4% |
| 2020 | 45% | +1% |
| 2019 | 44% | -1% |
| 2018 | 45% | +7% |
| 2017 | 38% | +2% |
| 2016 | 36% | +9% |
| 2015 | 27% | -8% |
| 2014 | 35% | +7% |
| 2013 | 28% | +1% |
| 2012 | 27% | +10% |
| 2011 | 17% | +3% |
| 2010 | 14% | +1% |
| 2009 | 13% | -3% |
| 2008 | 16% | +10% |
| 2007 | 6% | +1% |
| 2006 | 5% | +5% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |